What development
means for us

We develop formulations and processes based on our customers’ formulas. Our objective is stable and reproducible drug production. We focus on clinical phases II and III, but can also begin with phase 1 upon request. If you wish, we can transfer your existing production process directly.

Our services in the OEB 4 to 6 high potent range

 

  • Film-coated tablets, mini tablets and capsules
  • Batch sizes from 0.5 to 230 kg
  • Direct tableting, compacting, wet granulation and fluid bed granulation
  • Water-based coating preferred
  • Modified release dosage forms
  • Packaging in blister packs and bottles

 

Our services in the conventional area

 

  • FFilm-coated tablets and capsules
  • Batch sizes up to 500 kg
  • Direct tableting, compacting, wet granulation and fluid bed granulation
  • Water-based coating preferred
  • Modified release dosage forms
  • Packaging in blister packs and bottles